A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)
Clinical trial NCT02964338 · TERMINATED
Trial details
- NCT number
- NCT02964338
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-17
- Primary completion
- 2018-07-18
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.